Doug Schenkel
Stock Analyst at Wolfe Research
(2.83)
# 1,539
Out of 5,182 analysts
66
Total ratings
50%
Success rate
32.14%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $36.67 | +63.62% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $307.38 | +56.16% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $93.30 | -19.61% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $18.75 | +70.67% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $46.82 | +28.16% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $76.01 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $50.12 | +19.71% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $13.64 | +105.28% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $259.35 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $115.29 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $2.89 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $191.01 | +49.21% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $113.88 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $40.13 | +22.23% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $21.82 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $126.44 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $489.50 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.74 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $87.79 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.44 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $8.00 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $209.27 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.90 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.92 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.16 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.76 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.69 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $16.09 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.98 | +809.09% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $18.28 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $202.46 | -55.55% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.54 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $148.40 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $63.11 | -74.65% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $36.67
Upside: +63.62%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $307.38
Upside: +56.16%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $93.30
Upside: -19.61%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $18.75
Upside: +70.67%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $46.82
Upside: +28.16%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $76.01
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $50.12
Upside: +19.71%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $13.64
Upside: +105.28%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $259.35
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $115.29
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.89
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $191.01
Upside: +49.21%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $113.88
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $40.13
Upside: +22.23%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $21.82
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $126.44
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $489.50
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.74
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $87.79
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.44
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $8.00
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $209.27
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.90
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.92
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.16
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.76
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.69
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $16.09
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.98
Upside: +809.09%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $18.28
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $202.46
Upside: -55.55%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $3.54
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $148.40
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $63.11
Upside: -74.65%